Literature DB >> 7680082

Analysis of the epitopes of proliferating cell nuclear antigen recognized by monoclonal antibodies.

G Roos1, G Landberg, J P Huff, R Houghten, Y Takasaki, E M Tan.   

Abstract

BACKGROUND: Monoclonal antibodies to proliferating cell nuclear antigen (PCNA) are increasingly used for evaluation of cell proliferation especially in diagnostic pathology. To understand the different staining characteristics of such antibodies, we found it important to map the reactive epitopes in detail. EXPERIMENTAL
DESIGN: Overlapping, synthetic 15-mer peptides encoding the entire PCNA amino acid sequence were analyzed for reactivity with 6 anti-PCNA monoclonal antibodies using enzyme-linked immunosorbent assay and flow cytometric competition analysis. One immunodominant region was studied using a set of peptides with single amino acid substitutions. Further epitope localization was obtained by immunoblotting of fusion protein constructs.
RESULTS: The epitopes recognized by the antibodies could be assigned to specific peptides. Five monoclonal antibodies (19A2, 19F4, TO17, TO30, PC10) reacted with the same protein region (aa 111-125) whereas one antibody (TOB7) recognized a separate region of the protein (aa 181-195). The reactivity pattern with 8 recombinant PCNA-fusion proteins agreed with the peptide data. The immunodominant aa 111-125 peptide reactive antibodies differed concerning immunofluorescence patterns. These differences could be attributed to epitope microheterogeneity within this peptide as determined by reactivity with Ala-substituted peptides. The 19A2, 19F4 and PC10 antibodies showed nuclear fluorescence and similar but not identical peptide recognition patterns. Compared with 19A2 and 19F4, the PC10 antibody was directed against a simpler epitope. TO17 and TO30 gave cytoplasmic filamentous staining and their epitopes were different from those defined by the other monoclonal antibodies.
CONCLUSIONS: The results indicate that induced anti-PCNA antibodies recognize well defined linear epitopes, in contrast to PCNA autoepitopes which are strongly dependent on the protein conformation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7680082

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  16 in total

1.  Appearance of an inhibitory cell nuclear antigen in rat and human serum during variable degrees of hepatic regenerative activity.

Authors:  N Assy; YW Gong; M Zhang; GY Minuk
Journal:  World J Gastroenterol       Date:  1999-04       Impact factor: 5.742

2.  The effect of desalivation on the malignant transformation of the tongue epithelium and associated stromal myofibroblasts in a rat 4-nitroquinoline 1-oxide-induced carcinogenesis model.

Authors:  Marilena Vered; Osnat Grinstein-Koren; Shoshana Reiter; Irit Allon; Dan Dayan
Journal:  Int J Exp Pathol       Date:  2010-03-26       Impact factor: 1.925

3.  Recurrence of meningiomas versus proliferating cell nuclear antigen (PCNA) positivity and AgNOR counting.

Authors:  E Demirtaş; F Yilmaz; I Ovül; K Oner
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

4.  Association between nm23-H1 expression, proliferation and apoptosis in non-small cell lung carcinomas.

Authors:  M Volm; J Mattern; R Koomägi
Journal:  Clin Exp Metastasis       Date:  1998-10       Impact factor: 5.150

5.  Proliferative activity of keratinocytes correlates with that of melanocytes in naevi and melanomas.

Authors:  M Tronnier; R Kämmerer; H H Wolff
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

6.  Fixation requirements for the immunohistochemical reactivity of PCNA antibody PC10 on cryostat sections.

Authors:  H P Baum; J Reichrath; A Theobald; G Schock
Journal:  Histochem J       Date:  1994-12

7.  Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance.

Authors:  Ayman Khdair; Di Chen; Yogesh Patil; Linan Ma; Q Ping Dou; Malathy P V Shekhar; Jayanth Panyam
Journal:  J Control Release       Date:  2009-09-11       Impact factor: 9.776

8.  Lys-110 is essential for targeting PCNA to replication and repair foci, and the K110A mutant activates apoptosis.

Authors:  Byung Ju Kim; Hoyun Lee
Journal:  Biol Cell       Date:  2008-12       Impact factor: 4.458

9.  Cathepsin D immunoreactivity in ovarian cancer: correlation with prognostic factors.

Authors:  P Athanassiadou; V Sakellariou; E Petrakakou; P Athanassiades; C Zerva; A Liossi; S Michalas
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

10.  P53 accumulation and proliferating-cell nuclear antigen expression in human lung cancer.

Authors:  T Wiethege; B Voss; K M Müller
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.